Advertisement

ASO Author Reflections: Using Big Data to Overcome the Challenges of Studying a Rare Tumor

  • Reed I. Ayabe
  • Jonathan M. HernandezEmail author
ASO Author Reflections

Notes

Disclosures

Reed I. Ayabe and Jonathan M. Hernandez have no conflicts of interest to disclose.

References

  1. 1.
    Joel W. Karzinoid der Gallenblasse. Zentral-bl Allg Pathol 1929;46:1–4.Google Scholar
  2. 2.
    Kanetkar AV, Patkar S, Khobragade KH, Ostwal V, Ramaswamy A, Goel M. Neuroendocrine carcinoma of gallbladder: a step beyond palliative therapy, experience of 25 cases. J Gastrointest Cancer. 2019;50(2):298–303.CrossRefGoogle Scholar
  3. 3.
    Kamboj M, Gandhi JS, Gupta G, et al. Neuroendocrine carcinoma of gall bladder: a series of 19 cases with review of literature. J Gastrointest Cancer. 2015;46(4):356–364.CrossRefGoogle Scholar
  4. 4.
    Iype S, Mirza TA, Propper DJ, Bhattacharya S, Feakins RM, Kocher HM. Neuroendocrine tumours of the gallbladder: three cases and a review of the literature. Postgrad Med J. 2009;85(1002):213–218.CrossRefGoogle Scholar
  5. 5.
    Ayabe RI, Wach M, Ruff S, et al. Primary gallbladder neuroendocrine tumors: insights into a rare histology using a large national database. Ann Surg Oncol. 2019.  https://doi.org/10.1245/s10434-019-07440-6.Google Scholar
  6. 6.
    Li M, Liu F, Zhang Y, et al. Whole-genome sequencing reveals the mutational landscape of metastatic small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC). Cancer Lett. 2017;391:20–27.CrossRefGoogle Scholar

Copyright information

© This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection 2019

Authors and Affiliations

  1. 1.Surgical Oncology Program, National Cancer InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations